Nicholas Violand U.S. FDA
Nicholas Violand U.S. FDA Investigator/Drug National Expert, OMPTO, ORA
Nicholas A. Violand began his career with FDA in 2008 as an Investigator in the New Jersey District, which is now part of the Office of Pharmaceutical Quality Operations, Division I, within ORA. Focusing primarily on drug CGMP and pre-approval inspections both domestically and internationally, as well as inspections of compounding pharmacies in the State of New Jersey, he has experience with a wide variety of sterile and non-sterile dosage forms, and his work has resulted in many significant regulatory actions. He became a Drug Specialist in 2014, training and mentoring newer Investigators, and in 2018, a Drug National Expert within the Division of Pharmaceutical Quality Programs, where he continues inspectional work and a focus on training and inspection-related projects. Mr. Violand received a BS in Biotechnology from the School of Environmental and Biological Sciences at Rutgers University.